RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.
RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.